Cholesterol drug halted

Shares of Eli Lilly slide after it scrapped an experimental cholesterol drug that was once thought to have big potential.

This entry was posted in Biotech & Pharmaceuticals, NBR Show Clips. Bookmark the permalink.

Leave a Reply